Armistice Capital, LLC Volitionrx LTD Transaction History
Armistice Capital, LLC
- $6.51 Billion
- Q3 2025
A detailed history of Armistice Capital, LLC transactions in Volitionrx LTD stock. As of the latest transaction made, Armistice Capital, LLC holds 9,380,425 shares of VNRX stock, worth $3.1 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
9,380,425
Previous 8,493,074
10.45%
Holding current value
$3.1 Million
Previous $6.45 Million
1.18%
% of portfolio
0.1%
Previous 0.11%
Shares
5 transactions
Others Institutions Holding VNRX
# of Institutions
32Shares Held
26.3MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY12.5MShares$4.12 Million4.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.53MShares$504,9150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA878KShares$289,7960.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$170,3040.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il330KShares$108,7410.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $18.9M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...